Metraipolis › archive › dc_ccd01339ee5f

From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41138008
DOI
10.1007/s10238-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-11-09T01:38:17.410Z
SHA-256 of the archived text
0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639
Stable URL of this page
https://metraipolis.com/documento/dc_ccd01339ee5f

How to cite

From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008 — Europe PMC (en), https://europepmc.org/article/MED/41138008 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccd01339ee5f (Metraipolis archive dc_ccd01339ee5f, sha256 0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639)
BibTeX
@misc{dcccd01339ee5f,
  title = {From symptom scales to regulatory endpoints: the evolution and clinical impact of patient-reported outcome measures in myeloproliferative neoplasms — Europe PMC PMID:41138008},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41138008},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccd01339ee5f; sha256 0ceb38bfe75e832dd241eb355ae50d3c54df08af456804338436810169feb639},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41138008. Agents can read the archived copy with the MCP tool read_document.